本帖最后由 mab 于 2009-2-28 16:35 编辑
Thanks for SPY2009 for pulling the info together. I am a new frog in stock market, thought I could contribute what I know about biopharm to return the favors from HHs and other frogs at HT.
Pfizer w ...
maomi 发表于 2009-2-28 13:51 
I have some different opinions from maomi.
Small molecules are still have many advantages than large molecules, though one disadvantage is that its successful rate are lower than large molecules. Small molecules are easy to manufacture and have low cost. It is easy to administer to patient.
From biology perspective, small molecules have more targets than large molecules. Large molecules are protein based and they have to be manufactured using living cells, mainly CHO cells now.
I believe the breakthrough is to identify the right targets.
JM2C |